/Companies

Illumen Therapeutics

1 known investors

Find your way into Illumen Therapeutics

Sign up to see every warm intro you have to Illumen Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Illumen Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.

Investors · 1

Frequently asked questions

What does Illumen Therapeutics do?
Illumen Therapeutics is a biotech company developing first-in-class PARN inhibitor drugs that increase functional p53, a tumor suppressor, as a treatment for aggressive cancers. Its drug development focuses on targeting p53 dysregulation to improve cancer patient survival.
Who are Illumen Therapeutics's investors?
Illumen Therapeutics's investors include Colorado BioScience Association.